HealthCare Global Enterprises Ltd (HCG) Q3FY25 Concall Summary - Dec-2024 Qtr
Performance Overview
- HealthCare Global Enterprises Ltd (HCG) achieved its highest-ever quarterly revenue of INR 559 crores, a 19% year-over-year increase.
- Despite seasonal weakness, volumes increased across modalities, indicating market share growth.
- Adjusted EBITDA margin reached 16.5% for Q3 FY25, with adjusted EBITDA at INR 92.3 crores, a 15% YoY growth. PAT grew by 23%.
- Emerging centers performed well with 25% YoY growth, with Kolkata at 40% and South Mumbai at 28% growth.
- MG Hospital Vizag acquisition contributed to the expansion of HCG's footprint and service offerings.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.